Author:
Chen Bin,O'Connell Catherine D.,Boone D Joe,Amos Jean A.,Beck Jeanne C.,Chan Maria M.,Farkas Daniel H.,Lebo Roger V.,Richards Carolyn Sue,Roa Benjamin B.,Silverman Lawrence M.,Barton David E.,Bejjani Bassem A.,Belloni Dorothy R.,Bernacki Susan H.,Caggana Michele,Charache Patricia,Dequeker Elisabeth,Ferreira-Gonzalez Andrea,Friedman Kenneth J.,Greene Carol L.,Grody Wayne W.,Highsmith William Edward,Hinkel Cecelia S.,Kalman Lisa V.,Lubin Ira M.,Lyon Elaine,Payne Deborah A.,Pratt Victoria M.,Rohlfs Elizabeth,Rundell Clark A.,Schneider Erasmus,Willey Ann M.,Williams Laurina O.,Willey James C.,Winn-Deen Emily S.,Wolff Daynna J.
Reference54 articles.
1. Williams LO, Cole EC. General recommendations for quality assurance programs for laboratory molecular genetic tests. Final Monograph. 1999. http://www.phppo.cdc.gov/dls/pdf/genetics/dyncor.pdf Accessed April 2, 2005.
2. Association for Molecular Pathology. FDA-approved Molecular Diagnostics Tests. Available at: http://www.ampweb.org/FDAtable/FDAtablenov04.htm Accessed November 2, 2004.
3. Association for Molecular Pathology statement. Recommendations for in-house development and operation of molecular diagnostic tests. Am J Clin Pathol 1999; 111: 449–463.
4. American College of Obstetricians and Gynecologists, and American College of Medical Genetics. 2001. Preconception and prenatal carrier screening for cystic fibrosis. Clinical and Laboratory Guidelines. American College of Obstetricians and Gynecologists, Washington, DC.
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献